Hemolytic anemia and photosensitivity in infant

Authors

  • I Maaloul (1) Medical school of Sfax, department of pediatrics, CHU Hédi Chaker, Sfax, Tunisie. (2) Medical school of Sfax, department of dermatology, CHU Hédi Chaker, Sfax, Tunisie. Author
  • M Bahloul (1) Medical school of Sfax, department of pediatrics, CHU Hédi Chaker, Sfax, Tunisie. (2) Medical school of Sfax, department of dermatology, CHU Hédi Chaker, Sfax, Tunisie. Author
  • I Chabchoub (1) Medical school of Sfax, department of pediatrics, CHU Hédi Chaker, Sfax, Tunisie. (2) Medical school of Sfax, department of dermatology, CHU Hédi Chaker, Sfax, Tunisie. Author
  • H Aloulou (1) Medical school of Sfax, department of pediatrics, CHU Hédi Chaker, Sfax, Tunisie. (2) Medical school of Sfax, department of dermatology, CHU Hédi Chaker, Sfax, Tunisie. Author
  • H Turki (1) Medical school of Sfax, department of pediatrics, CHU Hédi Chaker, Sfax, Tunisie. (2) Medical school of Sfax, department of dermatology, CHU Hédi Chaker, Sfax, Tunisie. Author
  • S Ben Ameur (1) Medical school of Sfax, department of pediatrics, CHU Hédi Chaker, Sfax, Tunisie. (2) Medical school of Sfax, department of dermatology, CHU Hédi Chaker, Sfax, Tunisie. Author
  • T Kammoun (1) Medical school of Sfax, department of pediatrics, CHU Hédi Chaker, Sfax, Tunisie. (2) Medical school of Sfax, department of dermatology, CHU Hédi Chaker, Sfax, Tunisie. Author

Keywords:

congenital erythropoietic porphyria, infant, physiopathology, management, hemolytic anemia, photosensitivity

Abstract

Congenital erythropoietic porphyria (CEP) is a rare inherited metabolic disease which usually manifests in early childhood with severe cutaneous photosensitivity, dark red urine and a variable degree of haematological involvement ranging from a mild hemolytic anemia to intrauterine hydrops fetalis. We report the case of a 4-month-old infant who was admitted for severe hemolytic anemia and red urines, who developed secondary severe cutaneous photosensitivity. The diagnosis of CEP was established on the basis of clinical symptoms and increased values of uroporphyrinogen and coproporphyrinogen in the plasma and urine.

Downloads

Published

2021-09-30